Biotechnology

Wednesday Dec 06, 2023 - 11:43 am

InvestorNewsBreaks — Astiva Health Partners with IBN to Deliver Corporate Communications, Increase Awareness

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, has selected IBN, a versatile financial news and publishing company specializing in private and public entities, as a corporate communications partner. According to the announcement, the partnership is designed to enhance Astiva Health's corporate communications initiatives as the company focuses on its mission to deliver unparalleled quality care…

Tuesday Dec 05, 2023 - 2:38 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes Non-Brokered Private Placement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) today announced that it has closed a non-brokered private placement and issued 24 class A multiple voting shares of the company, each at a price of $1.90, for gross proceeds of $45.60 (the “offering”). All securities issued pursuant to the offering are subject to a statutory hold period of four months plus a day from issuance in…

Tuesday Dec 05, 2023 - 12:04 pm

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Releases Updated Report on Litigation

Safety Shot (NASDAQ: SHOT), makers of the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, is reporting on its newly filed lawsuit against Capybara Research. According to the update, the company filed a federal lawsuit in the U.S. District Court for the Southern District of New York against Capybara Research on Dec. 4, 2023. In…

Monday Dec 04, 2023 - 2:39 pm

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Recent H.C. Wainwright & Co. Research Report with ‘Buy’ Rating, $3 PT

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is spotlighted in a recent H.C. Wainwright & Co. research report. The report “is initiating coverage on PaxMedica, an emerging firm developing novel formulations of suramin for treatment of neurological disorders with intractable symptoms,” which is “attacking autism with a novel approach.” The report noted that PaxMedica was the first company to…

Monday Dec 04, 2023 - 1:27 pm

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces Sellout of Product ‘Almost Immediately’ After Being Released on Amazon.com

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced that its flagship product, Safety Shot, sold out within hours after being released on Amazon.com. The scientifically formulated beverage is the first patented beverage that helps consumers feel better faster by reducing blood alcohol content and boosting clarity. The announcement noted that the product was released on Amazon on Nov. 30, 2023, and without…

Friday Dec 01, 2023 - 2:52 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Targeting Confirmatory Support for Existing ALS Trial Data with NIH-Funded EAP Study

Clene’s (NASDAQ: CLNN) wholly owned subsidiary Clene Nanomedicine Inc. and its collaborators, Columbia University and Synapticure, recently received a four-year grant totaling $45.1 million. The grant will support an Expanded Access Protocol (“EAP”) study investigating the safety and efficacy of Clene’s investigational product (“IP”), CNM-Au8, as a treatment for people with amyotrophic lateral sclerosis (“ALS”). “CNM-Au8 is an orally administered gold nanocrystal suspension that is…

Friday Dec 01, 2023 - 1:57 pm

InvestorNewsBreaks – IBN and BioMedWire Extend Collaboration with Dynamic Global Events

IBN, a comprehensive communications organization with a diverse portfolio of 60+ brands, today announced its fourth consecutive year of collaboration with Dynamic Global Events (“DGE”), a leader in B2B conferences that serve the pharmaceutical and life sciences industries. IBN will serve as an official media partner for the upcoming DGE events in 2024. In addition, BioMedWire (“BMW”), a digital hub within IBN committed to highlighting…

Friday Dec 01, 2023 - 1:43 pm

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Eyes ‘Encouraging’ Results from CLEAR MIND Trial

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, in October announced topline results from its phase 2a CLEAR MIND trial, investigating Lomecel-B(TM) for the treatment of mild Alzheimer’s disease (“AD”). “Lomecel-B(TM) is an allogeneic medicinal signaling cell (‘MSC’). MSCs appear to possess anti-inflammatory, pro-vascular and pro-regenerative properties. The study met its primary safety endpoint across all study…

Thursday Nov 30, 2023 - 12:25 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), Celly Nu Complete Plan of Arrangement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) and Celly Nutrition Corp. (“Celly Nu”) today announced the closing of the previously proposed distribution of a portion of FSD Pharma’s holdings of common shares of Celly Nu (“Celly Nu shares”) to certain securityholders of FSD Pharma through a statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the “plan of arrangement”), per…

Wednesday Nov 29, 2023 - 1:05 pm

InvestorNewsBreaks – Branded Legacy Inc. (BLEG) Commences Buyback of 1M Preferred Class D Shares

Branded Legacy (OTC: BLEG), a pioneer in the biotechnology and wellness industries, announced its strategic decision to buy back and retire 1,000,000 Preferred Class D Shares. The significant move protects against a conversion ratio of 1 Preferred Class D Share to 100 Common Unrestricted shares, marking a pivotal step in enhancing shareholder value and simplifying Branded Legacy’s share structure by preventing these shares from entering…

Wednesday Nov 29, 2023 - 12:58 pm

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility

Scinai Immunotherapeutics (NASDAQ: SCNI) today announced the execution of a formal amendment to its finance contract with the European Investment Bank (“EIB”). According to the announcement, the amendment extends the maturity date of the contract by four years from Dec. 31, 2027, to Dec. 31, 2031. “I thank the EIB for their ongoing support and cooperation. As the lending arm of the European Union, the…

Tuesday Nov 28, 2023 - 11:59 am

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Issues update on GBB Drink Lab Inc. Litigation and Safety Shot

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company has issued a statement as an update regarding its litigation with GBB Drink Lab Inc. previously referenced at: FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. (NASDAQ: JUPW). In May of this year, GBB…

Monday Nov 27, 2023 - 12:18 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in Goldman Small Cap Research Report, Receives Approval for Celly Nu Plan of Arrangement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is spotlighted in a recent report released by Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors. The new report notes that through its wholly owned subsidiary, Lucid Psycheceuticals Inc., FSD is working to develop…

Monday Nov 27, 2023 - 10:20 am

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has closed its previously announced public offering. The offering was comprised of 5,384,615 shares of common stock (or common stock equivalents in lieu thereof) and warrants; the shares were offered at $1.30 per share (or common stock equivalent in lieu thereof) and accompanying warrant. According to the announcement, the warrants also had…

Wednesday Nov 22, 2023 - 3:05 pm

InvestorNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, was featured in a recent Proactive interview. Mark Dybul, CEO of Renovaro, joined host Steve Darling to talk about the company and its achievements and potential. Specifically, the two talked about the company’s recent signing of a definitive agreement to merge with GEDiCube,…

Wednesday Nov 22, 2023 - 2:47 pm

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Issues Warning to Shareholders

Safety Shot (NASDAQ: SHOT) today announced that it has come to its attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt to scare SHOT investors out of their positions in hopes of getting them to sell their shares so they can then buy at a lower cost to cover their disclosed…

Wednesday Nov 22, 2023 - 11:28 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Updated Safety Data from Berubicin Study at SNO Annual Gathering

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced the presentation of updated safety data from its ongoing potentially pivotal study evaluating Berubicin. According to the announcement, the data showed the comparability of the patient demographics in the two arms of the study, and of the safety…

Tuesday Nov 21, 2023 - 3:17 pm

InvestorNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to combine with the advanced AI company GEDiCube International Ltd, rebranding as Renovaro AI. “The company has also announced the addition of three new members to its board of directors – Avram Miller, Leni Boeren and Ruud Hendriks. Leni Boeren brings a 40-year career in the…

Tuesday Nov 21, 2023 - 12:31 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Approval of the Plan of Arrangement with Celly Nu

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that FSD Pharma securityholders (as defined in the announcement) have approved the previously disclosed plan of arrangement under section 182 of the Business Corporations Act (Ontario) pursuant to which common shares in the capital of Celly Nutrition Corp. (“Celly Nu”) will…

Monday Nov 20, 2023 - 12:45 pm

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Notification from NASDAQ of Regained Compliance with Stockholders’ Equity Rule

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, and providing end-to-end boutique CDMO services, has regained compliance with NASDAQ listing rules regarding minimum stockholders' equity. The company received formal notification of the status from NASDAQ. According to the announcement, NASDAQ indicated that the exchange had…

Monday Nov 20, 2023 - 11:10 am

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Set for Dec. 7 California Launch

Safety Shot (NASDAQ: SHOT) today announced the west coast launch of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot is a nutraceutical functional beverage, created by industry experts and validated by research, that accelerates the body’s break-down of alcohol while aiding in recovery and rehydration. “Our west coast launch…

Monday Nov 20, 2023 - 10:35 am

InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the pricing of its public offering of an aggregate of 5,384,615 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,384,615 shares of common stock, at a combined public offering price of $1.30 per share (or common stock equivalent in lieu…

Friday Nov 17, 2023 - 1:40 pm

InvestorNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Opportunity in Largely Untapped Precision Medicine Market

Renovaro BioSciences (NASDAQ: RENB), an advanced, preclinical biotechnology company, and GEDi Cube Intl Ltd., an AI medical technology company, previously announced a definitive agreement to combine. The move brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights and targeted immunotherapies. “According to CEO Dr. Mark Dybul, MD, the AI division intends to launch commercial products for…

Thursday Nov 16, 2023 - 11:50 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Release Interim Data by Year End for Lead Treatment Candidate Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its lead treatment candidates, Berubicin, with the public before the end of the year. Berubicin is a chemotherapy drug that interferes with the DNA of cancer…

Wednesday Nov 15, 2023 - 3:41 pm

InvestorNewsBreaks – NextPlat Corp.’s (NASDAQ: NXPL) Strong Growth Featured in Proactive Podcast

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, was featured in an interview with Proactive, where its CEO Charlie Fernandez joined host Steve Darling to provide an update on the company’s latest financial results. NextPlat has made impressive strides in consolidating its global e-commerce and Progressive Care health care operations, leading to significant growth. During the interview, Fernandez highlighted the company’s strong financial performance in…

Wednesday Nov 15, 2023 - 12:59 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Filing of Supplement to Management Information Circular

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has filed a supplement related to certain restrictions on resale that will apply to the Celly Nu shares that will be distributed to the FSD Pharma securityholders. The company filed the supplement, dated Nov. 15, 2023, as an addition to the Management Information…

Wednesday Nov 15, 2023 - 10:08 am

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2023 Financial Report, Operational Update

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for artificial intelligence (“AI”), is reporting its financial and operational results for the third quarter ended Sept. 30, 2023. Highlights of the report include the publication of a foundational study demonstrating the ability…

Tuesday Nov 14, 2023 - 2:26 pm

InvestorNewsBreaks – SOHM Inc. (SHMN) Unveils New Suite of SOHM Nutrients’ Brand Chewables

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has announced a new suite of products in the vitamin gummies space. Provided by the SOHM OTC Self-Care business unit, the new line includes 13 new SOHM Nutrients’ Brand Chewables. The new suite of chewable products offers an array of key benefits, including bone and skin…

Tuesday Nov 14, 2023 - 1:23 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today released financial results for the first quarter of the fiscal year 2024, which ended Sept. 30, 2023. “We are pleased with the continued advancements across our pharmaceutical programs and commercial operations. We are particularly excited with the recent candidate selection and official launch of…

Tuesday Nov 14, 2023 - 12:14 pm

InvestorNewsBreaks – Progressive Care Inc. (RXMD), NextPlat Corp. (NASDAQ: NXPL) Announce Strong Q3 2023 Results

Progressive Care (OTCQB: RXMD), a personalized health care services and technology provider, today announced financial results for its third quarter ended Sept. 30, 2023. Among the highlights, the company reported record third quarter revenues of $12 .4 million, a 22% increase in comparison to the prior year period, driven primarily by strong growth at its PharmcoRx pharmacies. “We are thrilled with our third quarter results…

Tuesday Nov 14, 2023 - 10:43 am

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Featured in Bell2Bell Podcast

Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Longeveron’s CEO Wa’el Hashad joined the program to introduce the company and its business model. “Longeveron is a cell therapy-based biotech company. It…

Monday Nov 13, 2023 - 9:50 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s 2023 Scientific Sessions

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-Related Frailty, is reporting on data from a long-term study. According to the announcement, extended long-term, follow-up data from Longeveron’s ELPIS I trial of Lomecel-B(TM) for patients with hypoplastic left heart syndrome (“HLHS”) is being presented as a poster at…

Thursday Nov 09, 2023 - 3:31 pm

InvestorNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions

SOHM (OTC: SHMN), a global generic drug innovator, recently completed the acquisition of a disruptive stem cell technology ABBIE (A Binding Based Integrating Enzyme) and patents from CGA Intellectual Holdings Inc. “[The acquisition] will allow the company to create regenerative medicine and cosmeceutical products for commercialization during the next year. SOHM’s acquisition of ABBIE grants it the ability to edit genes of a large number…

Thursday Nov 09, 2023 - 11:29 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced the expansion of its scientific advisory board (“SAB”) to include several leading cardiologists. New members include Charles L. Brown III, MD, CEO of the Piedmont Healthcare Physician Enterprise, Tony Das, MD, a nationally recognized board-certified interventional cardiology specialist,…

Thursday Nov 09, 2023 - 9:46 am

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is in the spotlight during a recent episode of The Bell2Bell podcast. During the podcast, PaxMedica chief medical officer David Hough and host Stuart Smith discuss key company achievements, including the company’s recent meeting with the U.S. Food and Drug Administration (“FDA”). Highlights mentioned during the podcast include the discussion with the…

Wednesday Nov 08, 2023 - 3:21 pm

InvestorNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI and Biotherapeutics

Renovaro BioSciences (NASDAQ: RENB), a preclinical biotechnology company involved in the development of enhanced gene, cell and immunotherapy platforms that modulate immune responses against cancers and infectious disease, and GEDi Cube International Ltd., an AI medical technology company, recently entered a definitive agreement to combine in a stock-for-stock acquisition. “The combined company will feature two main divisions: the AI division and the immunotherapy division, according…

Wednesday Nov 08, 2023 - 10:49 am

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) to Serve as Official Title Sponsor of ‘A Special Private Evening with Luke Bryan’

Safety Shot (NASDAQ: SHOT) today announced that it is the official title sponsor of Save Our Musicians event, “A Special Private Evening with Luke Bryan.” At the charity concert event taking place on Nov. 18, 2023, in Jupiter, Florida, country superstar and American Idol judge Luke Bryan will be performing to raise money for the arts in public schools. The concert follows a similar successful…

Tuesday Nov 07, 2023 - 1:35 pm

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Granted 3rd US Patent on Novel VECG Platform

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced that the United States Patent and Trademark Office has granted a new patent on its VECG platform. Patent number 11,793,444, “Electrocardiogram Patch Devices and Methods,” describes methods and systems for remote detection and/or diagnosis of acute myocardial infarction…

Tuesday Nov 07, 2023 - 10:41 am

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Phase 2 Study Results Published in Peer-Reviewed Journal

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is reporting that its phase 2 study research exploring the potential of low-dose suramin intravenous infusions as an autism spectrum disorder (“ASD”) treatment has been published. According to the announcement, the findings from the study were published in the “Annals of General Psychiatry.” The company noted that the research had been led…

Tuesday Nov 07, 2023 - 10:12 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Q3 2023 Financial Results, Operating Highlights

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., today released its third quarter 2023 financial results and provided recent operating highlights for its ALS clinical program. Among the highlights, the company reported statistically significant improved survival benefit of 19.3 months and significantly delayed clinical worsening in patients treated with CNM-Au8(R) in the RESCUE ALS open-label extension trial.…

InvestorNewsBreaks

NewsBreak Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions